المؤلفون: Yutaro Kaneko, Ryo Hatano, Naoto Hirota, Nicolas Isambert, Véronique Trillet-Lenoir, Benoit You, Jérôme Alexandre, Gérard Zalcman, Fanny Valleix, Thomas Podoll, Yoshimi Umezawa, Seiichi Takao, Satoshi Iwata, Osamu Hosono, Tetsuo Taguchi, Taketo Yamada, Nam H. Dang, Kei Ohnuma, Eric Angevin, Chikao Morimoto

المصدر: Biomarker Research, Vol 9, Iss 1, Pp 1-13 (2021)

مصطلحات موضوعية: Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2050-7771

URL الوصول: https://doaj.org/article/869532e7d9924a45b065a8c40a83cd05

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_1_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302935

الاتاحة: https://doi.org/10.6084/m9.figshare.14302935.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_2_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302938

الاتاحة: https://doi.org/10.6084/m9.figshare.14302938.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_5_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302950

الاتاحة: https://doi.org/10.6084/m9.figshare.14302950.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_4_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302947

الاتاحة: https://doi.org/10.6084/m9.figshare.14302947.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_6_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302953

الاتاحة: https://doi.org/10.6084/m9.figshare.14302953.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_3_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302941

الاتاحة: https://doi.org/10.6084/m9.figshare.14302941.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_8_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302959

الاتاحة: https://doi.org/10.6084/m9.figshare.14302959.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_9_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302962

الاتاحة: https://doi.org/10.6084/m9.figshare.14302962.v1

المؤلفون: Yutaro Kaneko (10433586), Ryo Hatano (513315), Naoto Hirota (10433589), Nicolas Isambert (2186692), Véronique Trillet-Lenoir (3457715), Benoit You (3457706), Jérôme Alexandre (6504179), Gérard Zalcman (310344), Fanny Valleix (10433592), Thomas Podoll (10433595), Yoshimi Umezawa (10433598), Seiichi Takao (10433601), Satoshi Iwata (425199), Osamu Hosono (290916), Tetsuo Taguchi (10433604), Taketo Yamada (135877), Nam H. Dang (513317), Kei Ohnuma (408118), Eric Angevin (10433607), Chikao Morimoto (290914)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Cancer, Serum soluble CD26/dipeptidyl peptidase 4, YS110, Prognostic biomarker, Cancer therapy

Relation: https://figshare.com/articles/presentation/Additional_file_7_of_Serum_soluble_CD26_DPP4_titer_variation_is_a_potential_prognostic_biomarker_in_cancer_therapy_with_a_humanized_anti-CD26_antibody/14302956

الاتاحة: https://doi.org/10.6084/m9.figshare.14302956.v1

المؤلفون: Fanny Valleix, Tetsuo Taguchi, Benoit You, Yutaro Kaneko, Thomas Podoll, Naoto Hirota, Nicolas Isambert, Kei Ohnuma, Ryo Hatano, Gérard Zalcman, Nam H. Dang, Eric Angevin, Véronique Trillet-Lenoir, Seiichi Takao, Yoshimi Umezawa, Taketo Yamada, Chikao Morimoto, Osamu Hosono, Satoshi Iwata, Jérôme Alexandre

المصدر: Biomarker Research
Biomarker Research, Vol 9, Iss 1, Pp 1-13 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Prognostic biomarker, Cancer therapy, medicine.drug_class, Clinical Biochemistry, Monoclonal antibody, 03 medical and health sciences, 0302 clinical medicine, Text mining, Stable Disease, Internal medicine, medicine, Progression-free survival, Receiver operating characteristic, biology, business.industry, Research, lcsh:RM1-950, Biochemistry (medical), medicine.disease, Titer, lcsh:Therapeutics. Pharmacology, 030104 developmental biology, 030220 oncology & carcinogenesis, Serum soluble CD26/dipeptidyl peptidase 4, biology.protein, YS110, Molecular Medicine, Antibody, business, Progressive disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ce65814344ffa433e56209cace7b82
https://doi.org/10.21203/rs.3.rs-126614/v1

المؤلفون: Takuhei Shoji, Hiroki Sato, Atsushi Mizukawa, Naoto Hirota, Toshio Enoki, Teruo Kojima, Takayuki Kanda, Masaru Takeuchi

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: http://iovs.arvojournals.org/data/Journals/IOVS/932986/i1552-5783-54-9-6242.pdf.

وصف الملف: application/pdf

Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1048.799; http://iovs.arvojournals.org/data/Journals/IOVS/932986/i1552-5783-54-9-6242.pdf

الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1048.799
http://iovs.arvojournals.org/data/Journals/IOVS/932986/i1552-5783-54-9-6242.pdf

المؤلفون: Takuhei Shoji, Atsushi Mizukawa, Toshio Enoki, Hiroki Sato, Naoto Hirota, Teruo Kojima, Takayuki Kanda, Masaru Takeuchi

المصدر: Investigative Opthalmology & Visual Science. 54:6242

مصطلحات موضوعية: Male, Intraocular pressure, genetic structures, Timolol, law.invention, chemistry.chemical_compound, Travoprost, Randomized controlled trial, Dorzolamide, law, medicine, Humans, Single-Blind Method, Low Tension Glaucoma, Prospective Studies, Latanoprost, Antihypertensive Agents, Intraocular Pressure, Aged, Cross-Over Studies, business.industry, Cloprostenol, Middle Aged, eye diseases, chemistry, Tolerability, Anesthesia, Prostaglandins F, Synthetic, Drug Therapy, Combination, Female, sense organs, Latanoprost/timolol, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea9332732b7325367c12145a84ebd2c
https://doi.org/10.1167/iovs.13-11942